when were glp 1 agonists approved for weight loss GLP-1 Drugs Market Report, 2025-2030 Indications for GLP-1/GIP RA Summary
Description
It is HERE
It helps control appetite, improve insulin sensitivity, and support metabolic health, while Vitamin B12 increases energy and overall wellness
95% CI 0.35, 3.14)
Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
functional benefits)
